During the past decade, Pluta Cancer Center conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Pluta Cancer Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 3 trials, followed by "University of Rochester" with 2 trials sponsored, "NSABP Foundation Inc" with 1 trials sponsored, "National Cancer Institute (NCI)" with 1 trials sponsored and "Novartis" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pluta Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 4 trials as a collaborator, "Bayer" with 2 trials as a collaborator, "Canadian Cancer Trials Group" with 1 trials as a collaborator, "Radiation Therapy Oncology Group" with 1 trials as a collaborator and "Seagen Inc." with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Pluta Cancer Center" are "Cancer" (2 trials), "Colonic Neoplasms" (2 trials), "Colorectal Neoplasms" (2 trials), "Rectal Neoplasms" (2 trials) and "Stage II Breast Cancer" (2 trials). Many other conditions were trialed in "Pluta Cancer Center" in a lesser frequency.

Most popular intervention types in "Pluta Cancer Center" are "Drug" (5 trials), "Other" (3 trials), "Radiation" (3 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (2 trials), "Questionnaire Administration" (2 trials), "Vatalanib" (2 trials), "Axillary Lymph Node Dissection" (1 trials) and "Axillary Lymph Node Dissection (ALND)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Pluta Cancer Center" are 7 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Pluta Cancer Center". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Pluta Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pluta Cancer Center, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".